Towards the end of the year, donated batches of the anti-HIV jab CAB-LA will arrive in South Africa. The two-monthly jab will be used in implementation trials and virtually wipes out one’s chances of contracting HIV through sex.
How much will donors and the South African health department have to pay for such injections? And can the drugmaker, ViiV Healthcare, make enough of them?
LISTEN | Bhekisisa: When & how the anti-HIV jab is coming to South Africa
Image: Robert Michael/Pool via Reuters
Towards the end of the year, donated batches of the anti-HIV jab CAB-LA will arrive in South Africa. The two-monthly jab will be used in implementation trials and virtually wipes out one’s chances of contracting HIV through sex.
How much will donors and the South African health department have to pay for such injections? And can the drugmaker, ViiV Healthcare, make enough of them?
In this podcast, Mia Malan asks Mitchell Warren, who leads a group of organisations and donors who look at ways to make the jab available as fast as possible, for answers.
This story was produced by the Bhekisisa Centre for Health Journalism. Sign up for the newsletter.
MORE:
BHEKISISA | Why poor mental health flags the need for HIV testing
BHEKISISA | More than a million South Africans using HIV prevention pill
BHEKISISA | M72: Three things you need to know about a TB jab that might work
WATCH | Goal is to get price as low as possible, says HIV jab producer as Sahpra registers drug
If the price is right, the anti-HIV jab could be in clinics by August 2023
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
News and promos in your inbox
subscribeMost read
Latest Videos